Bio-Rad Laboratories, Inc. Share Price NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
01:40:00 21/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 365.08 USD | +8.33% |
|
-.--% | +17.50% |
| Market Cap | 974.73Cr 872.58Cr 813.43Cr 737.8Cr 1.39TCr 93TCr 1.4TCr 9.78TCr 3.83TCr 48TCr 3.66TCr 3.58TCr 1,54700Cr | P/E 2026 * |
43.8x | P/E 2027 * | 42.8x |
|---|---|---|---|---|---|
| Enterprise Value | 899.82Cr 805.52Cr 750.92Cr 681.1Cr 1.28TCr 86TCr 1.29TCr 9.02TCr 3.53TCr 44TCr 3.38TCr 3.31TCr 1,42800Cr | EV / Sales 2026 * |
3.5x | EV / Sales 2027 * | 3.35x |
| Free-Float |
60.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BIO.B | Delayed | |
Deutsche Boerse AG
| BUW | Delayed |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +8.33% | ||
| 3 months | +22.30% | ||
| 6 months | +31.80% | ||
| Current year | +17.50% |
| Current year | 244.54 |  | 365.08 |
| 1 year | 244.54 | | 365.08 |
| 3 years | 0 | | 365.08 |
| 5 years | 0 | | 784.4 |
| 10 years | 0 | | 818.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.33% | -.--% | - | - | 978.5Cr | |
| +2.23% | +1.72% | -23.20% | +12.89% | 17TCr | |
| +3.90% | +4.50% | -3.69% | +28.95% | 11TCr | |
| +1.90% | -0.92% | -22.49% | +11.33% | 11TCr | |
| +0.27% | +1.56% | -46.32% | -11.83% | 7.53TCr | |
| +0.37% | +3.22% | +2.22% | +73.30% | 6.18TCr | |
| +0.58% | +2.27% | +15.06% | +60.71% | 5.29TCr | |
| +2.80% | +4.55% | +1.25% | -26.52% | 5.01TCr | |
| +1.15% | -0.59% | -14.97% | +22.33% | 4.08TCr | |
| -1.38% | -0.11% | - | - | 3.18TCr | |
| Average | +1.97% | +2.43% | -11.52% | +21.40% | 7.83TCr | |
| Weighted average by Cap. | +1.82% | +2.34% | -14.73% | +19.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 256.95Cr 230.02Cr 214.43Cr 194.49Cr 366.83Cr 25TCr 369.13Cr 2.58TCr 1.01TCr 13TCr 965.2Cr 943.82Cr 41TCr | 262.42Cr 234.92Cr 218.99Cr 198.63Cr 374.64Cr 25TCr 376.99Cr 2.63TCr 1.03TCr 13TCr 985.75Cr 963.91Cr 42TCr |
| Net income | 22Cr 20Cr 19Cr 17Cr 32Cr 2.15TCr 32Cr 225.49Cr 88Cr 1.11TCr 84Cr 83Cr 3.57TCr | 23Cr 21Cr 19Cr 17Cr 33Cr 2.2TCr 33Cr 230.38Cr 90Cr 1.13TCr 86Cr 84Cr 3.65TCr |
| Net Debt | -75Cr -67Cr -63Cr -57Cr -106.93Cr -7.16TCr -107.6Cr -751.17Cr -294.06Cr -3.69TCr -281.36Cr -275.13Cr -12TCr | -97Cr -86Cr -81Cr -73Cr -137.83Cr -9.23TCr -138.69Cr -968.2Cr -379.01Cr -4.76TCr -362.65Cr -354.62Cr -15TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | $0.000000 | - | 4 |
| 09/26/09 | $0.000000 | - | 8 |
| 08/26/08 | $0.000000 | - | 11 |
| 07/26/07 | $0.000000 | - | 13 |
| 06/26/06 | $0.000000 | - | 10 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
Select your edition
All financial news and data tailored to specific country editions
